Controllability of spin-boson systems

In this paper we study the so-called spin-boson system, namely {a two-level system} in interaction with a distinguished mode of a quantized bosonic field. We give a brief description of the controlled Rabi and Jaynes--Cummings models and we discuss their appearance in the mathematics and physics literature. We then study the controllability of the Rabi model when the control is an external field acting on the bosonic part. Applying geometric control techniques to the Galerkin approximation and using perturbation theory to guarantee non-resonance of the spectrum of the drift operator, we prove approximate controllability of the system, for almost every value of the interaction parameter

Quantum control of ro-vibrational dynamics and application to light-induced molecular chirality

Achiral molecules can be made temporarily chiral by excitation with electric fields, in the sense that an average over molecular orientations displays a net chiral signal [Tikhonov et al., Sci. Adv. 8, eade0311 (2022)]. Here, we go beyond the assumption of molecular orientations to remain fixed during the excitation process. Treating both rotations and vibrations quantum mechanically, we identify conditions for the creation of chiral vibrational wavepackets -- with net chiral signals -- in ensembles of achiral molecules which are initially randomly oriented. Based on the analysis of symmetry and controllability, we derive excitation schemes for the creation of chiral wavepackets using a combination of (a) microwave and IR pulses and (b) a static field and a sequence of IR pulses. These protocols leverage quantum rotational dynamics for pump-probe spectroscopy of chiral vibrational dynamics, extending the latter to regions of the electromagnetic spectrum other than the UV.Comment: 16 pages, 8 figure

Full quantum control of enantiomer-selective state transfer in chiral molecules despite degeneracy

The driven quantum asymmetric top is an important paradigm in molecular physics with applications ranging from quantum information to chiral-sensitive spectroscopy. A key prerequisite for these applications is the ability to completely control the rotational dynamics. The inherent degeneracy of quantum rotors poses a challenge for quantum control since selecting a particular rotational state cannot be achieved by spectral selection alone. Here, we prove complete controllability for rotational states of an asymmetric top belonging to degenerate values of the orientational quantum number M. Based on this insight, we construct a pulse sequence that energetically separates population in degenerate M-states. Introducing the concept of enantio-selective controllability, we determine the conditions for complete enantiomer-specific population transfer in chiral molecules and construct pulse sequences for the example of propanediol and carvone molecules for population initially distributed over degenerate M-states. Our work shows how to leverage controllability analysis for the solution of practical quantum control problems

Adiabatic passage and ensemble control of quantum systems

This paper considers population transfer between eigenstates of a finite quantum ladder controlled by a classical electric field. Using an appropriate change of variables, we show that this setting can be set in the framework of adiabatic passage, which is known to facilitate ensemble control of quantum systems. Building on this insight, we present a mathematical proof of robustness for a control protocol -- chirped pulse -- practiced by experimentalists to drive an ensemble of quantum systems from the ground state to the most excited state. We then propose new adiabatic control protocols using a single chirped and amplitude shaped pulse, to robustly perform any permutation of eigenstate populations, on an ensemble of systems with badly known coupling strengths. Such adiabatic control protocols are illustrated by simulations achieving all 24 permutations for a 4-level ladder

Protostellar collapse induced by compression. II: rotation and fragmentation

We investigate numerically and semi-analytically the collapse of low-mass, rotating prestellar cores. Initially, the cores are in approximate equilibrium with low rotation (the initial ratio of thermal to gravitational energy is $\alpha_0 \simeq 0.5$, and the initial ratio of rotational to gravitational energy is $\beta_0 = 0.02 {\rm to} 0.05$). They are then subjected to a steady increase in external pressure. Fragmentation is promoted -- in the sense that more protostars are formed -- both by more rapid compression, and by higher rotation (larger $\beta_0$). In general, the large-scale collapse is non-homologous, and follows the pattern described in Paper I for non-rotating clouds, viz. a compression wave is driven into the cloud, thereby increasing the density and the inflow velocity. The effects of rotation become important at the centre, where the material with low angular momentum forms a central primary protostar (CPP), whilst the material with higher angular momentum forms an accretion disc around the CPP. More rapid compression drives a stronger compression wave and delivers material more rapidly into the outer parts of the disc.Comment: 17 pages, accepted for publication in MNRA

Whole genome methylation profiles as independent markers of survival in stage IIIc melanoma patients

Background: The clinical course of cutaneous melanoma (CM) can differ significantly for patients with identical stages of disease, defined clinico-pathologically, and no molecular markers differentiate patients with such a diverse prognosis. This study aimed to define the prognostic value of whole genome DNA methylation profiles in stage III CM.Methods: Genome-wide methylation profiles were evaluated by the Illumina Human Methylation 27 BeadChip assay in short-term neoplastic cell cultures from 45 stage IIIC CM patients. Unsupervised K-means partitioning clustering was exploited to sort patients into 2 groups based on their methylation profiles. Methylation patterns related to the discovered groups were determined using the nearest shrunken centroid classification algorithm. The impact of genome-wide methylation patterns on overall survival (OS) was assessed using Cox regression and Kaplan-Meier analyses.Results: Unsupervised K-means partitioning by whole genome methylation profiles identified classes with significantly different OS in stage IIIC CM patients. Patients with a " favorable" methylation profile had increased OS (P = 0.001, log-rank = 10.2) by Kaplan-Meier analysis. Median OS of stage IIIC patients with a " favorable" vs. " unfavorable" methylation profile were 31.5 and 10.4 months, respectively. The 5 year OS for stage IIIC patients with a " favorable" methylation profile was 41.2% as compared to 0% for patients with an " unfavorable" methylation profile. Among the variables examined by multivariate Cox regression analysis, classification defined by methylation profile was the only predictor of OS (Hazard Ratio = 2.41, for " unfavorable" methylation profile; 95% Confidence Interval: 1.02-5.70; P = 0.045). A 17 gene methylation signature able to correctly assign prognosis (overall error rate = 0) in stage IIIC patients on the basis of distinct methylation-defined groups was also identified.Conclusions: A discrete whole-genome methylation signature has been identified as molecular marker of prognosis for stage IIIC CM patients. Its use in daily practice is foreseeable, and promises to refine the comprehensive clinical management of stage III CM patients. © 2012 Sigalotti et al.; licensee BioMed Central Ltd

The Italian Network for Tumor Biotherapy (NIBIT): Getting together to push the field forward

As for a consolidated tradition, the 5th annual meeting of the Italian Network for Cancer Biotherapy took place in the Certosa of Pontignano, a Tuscan monastery, on September 20–22, 2007. The congress gathered more than 40 Italian leading groups representing academia, biotechnology and pharmaceutical industry. Aim of the meeting was to share new advances in cancer bio-immunotherapy and to promote their swift translation from pre-clinical research to clinical applications. Several topics were covered including: a) molecular and cellular mechanisms of tumor escape; b) therapeutic antibodies and recombinant constructs; c) clinical trials up-date and new programs; d) National Cooperative Networks and their potential interactions; e) old and new times in cancer immunology, an "amarcord". Here, we report the main issues discussed during the meeting

Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies

Cutaneous melanoma is a very aggressive neoplasia of melanocytic origin with constantly growing incidence and mortality rates world-wide. Epigenetic modifications (i.e., alterations of genomic DNA methylation patterns, of post-translational modifications of histones, and of microRNA profiles) have been recently identified as playing an important role in melanoma development and progression by affecting key cellular pathways such as cell cycle regulation, cell signalling, differentiation, DNA repair, apoptosis, invasion and immune recognition. In this scenario, pharmacologic inhibition of DNA methyltransferases and/or of histone deacetylases were demonstrated to efficiently restore the expression of aberrantly-silenced genes, thus re-establishing pathway functions. In light of the pleiotropic activities of epigenetic drugs, their use alone or in combination therapies is being strongly suggested, and a particular clinical benefit might be expected from their synergistic activities with chemo-, radio-, and immuno-therapeutic approaches in melanoma patients. On this path, an important improvement would possibly derive from the development of new generation epigenetic drugs characterized by much reduced systemic toxicities, higher bioavailability, and more specific epigenetic effects

Missense mutations in Desmocollin-2 N-terminus, associated with arrhythmogenic right ventricular cardiomyopathy, affect intracellular localization of desmocollin-2 in vitro

<p>Abstract</p> <p>Background</p> <p>Mutations in genes encoding desmosomal proteins have been reported to cause arrhythmogenic right ventricular cardiomyopathy (ARVC), an autosomal dominant disease characterised by progressive myocardial atrophy with fibro-fatty replacement.</p> <p>We screened 54 ARVC probands for mutations in desmocollin-2 (<it>DSC2</it>), the only desmocollin isoform expressed in cardiac tissue.</p> <p>Methods</p> <p>Mutation screening was performed by denaturing high-performance liquid chromatography and direct sequencing.</p> <p>To evaluate the pathogenic potentials of the <it>DSC2 </it>mutations detected in patients affected with ARVC, full-length wild-type and mutated cDNAs were cloned in eukaryotic expression vectors to obtain a fusion protein with green fluorescence protein (GFP); constructs were transfected in neonatal rat cardiomyocytes and in HL-1 cells.</p> <p>Results</p> <p>We identified two heterozygous mutations (c.304G>A (p.E102K) and c.1034T>C (p.I345T)) in two probands and in four family members. The two mutations p.E102K and p.I345T map to the N-terminal region, relevant to adhesive interactions.</p> <p>In vitro functional studies demonstrated that, unlike wild-type DSC2, the two N-terminal mutants are predominantly localised in the cytoplasm.</p> <p>Conclusion</p> <p>The two missense mutations in the N-terminal domain affect the normal localisation of DSC2, thus suggesting the potential pathogenic effect of the reported mutations. Identification of additional DSC2 mutations associated with ARVC may result in increased diagnostic accuracy with implications for genetic counseling.</p